These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 28519902)
1. Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons. Piacentini R; Li Puma DD; Mainardi M; Lazzarino G; Tavazzi B; Arancio O; Grassi C Glia; 2017 Aug; 65(8):1302-1316. PubMed ID: 28519902 [TBL] [Abstract][Full Text] [Related]
2. Intracellular accumulation of tau oligomers in astrocytes and their synaptotoxic action rely on Amyloid Precursor Protein Intracellular Domain-dependent expression of Glypican-4. Puliatti G; Li Puma DD; Aceto G; Lazzarino G; Acquarone E; Mangione R; D'Adamio L; Ripoli C; Arancio O; Piacentini R; Grassi C Prog Neurobiol; 2023 Aug; 227():102482. PubMed ID: 37321444 [TBL] [Abstract][Full Text] [Related]
3. Effect of Aβ Oligomers on Neuronal APP Triggers a Vicious Cycle Leading to the Propagation of Synaptic Plasticity Alterations to Healthy Neurons. Rolland M; Powell R; Jacquier-Sarlin M; Boisseau S; Reynaud-Dulaurier R; Martinez-Hernandez J; André L; Borel E; Buisson A; Lanté F J Neurosci; 2020 Jul; 40(27):5161-5176. PubMed ID: 32444385 [TBL] [Abstract][Full Text] [Related]
4. Interaction between NH(2)-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration. Amadoro G; Corsetti V; Atlante A; Florenzano F; Capsoni S; Bussani R; Mercanti D; Calissano P Neurobiol Aging; 2012 Apr; 33(4):833.e1-25. PubMed ID: 21958963 [TBL] [Abstract][Full Text] [Related]
6. Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific. Zago W; Buttini M; Comery TA; Nishioka C; Gardai SJ; Seubert P; Games D; Bard F; Schenk D; Kinney GG J Neurosci; 2012 Feb; 32(8):2696-702. PubMed ID: 22357853 [TBL] [Abstract][Full Text] [Related]
7. Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits. Miller EC; Teravskis PJ; Dummer BW; Zhao X; Huganir RL; Liao D Eur J Neurosci; 2014 Apr; 39(7):1214-24. PubMed ID: 24713000 [TBL] [Abstract][Full Text] [Related]
8. The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation. Mairet-Coello G; Courchet J; Pieraut S; Courchet V; Maximov A; Polleux F Neuron; 2013 Apr; 78(1):94-108. PubMed ID: 23583109 [TBL] [Abstract][Full Text] [Related]
9. A novel subtype of astrocytes expressing TRPV4 (transient receptor potential vanilloid 4) regulates neuronal excitability via release of gliotransmitters. Shibasaki K; Ikenaka K; Tamalu F; Tominaga M; Ishizaki Y J Biol Chem; 2014 May; 289(21):14470-80. PubMed ID: 24737318 [TBL] [Abstract][Full Text] [Related]
10. Heterosynaptic long-term depression mediated by ATP released from astrocytes. Chen J; Tan Z; Zeng L; Zhang X; He Y; Gao W; Wu X; Li Y; Bu B; Wang W; Duan S Glia; 2013 Feb; 61(2):178-91. PubMed ID: 23044720 [TBL] [Abstract][Full Text] [Related]
11. A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway. Han Y; Chen L; Liu J; Chen J; Wang C; Guo Y; Yu X; Zhang C; Chu H; Ma H Molecules; 2022 Jun; 27(13):. PubMed ID: 35807406 [TBL] [Abstract][Full Text] [Related]
12. Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells. Usenovic M; Niroomand S; Drolet RE; Yao L; Gaspar RC; Hatcher NG; Schachter J; Renger JJ; Parmentier-Batteur S J Neurosci; 2015 Oct; 35(42):14234-50. PubMed ID: 26490863 [TBL] [Abstract][Full Text] [Related]
13. CRAC channels regulate astrocyte Ca Toth AB; Hori K; Novakovic MM; Bernstein NG; Lambot L; Prakriya M Sci Signal; 2019 May; 12(582):. PubMed ID: 31113852 [TBL] [Abstract][Full Text] [Related]
15. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease. Saul A; Sprenger F; Bayer TA; Wirths O Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045 [TBL] [Abstract][Full Text] [Related]
16. Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies. Dejanovic B; Huntley MA; De Mazière A; Meilandt WJ; Wu T; Srinivasan K; Jiang Z; Gandham V; Friedman BA; Ngu H; Foreman O; Carano RAD; Chih B; Klumperman J; Bakalarski C; Hanson JE; Sheng M Neuron; 2018 Dec; 100(6):1322-1336.e7. PubMed ID: 30392797 [TBL] [Abstract][Full Text] [Related]
18. Gliotransmission and the tripartite synapse. Santello M; Calì C; Bezzi P Adv Exp Med Biol; 2012; 970():307-31. PubMed ID: 22351062 [TBL] [Abstract][Full Text] [Related]
19. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport. Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715 [TBL] [Abstract][Full Text] [Related]
20. Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton. Zempel H; Mandelkow EM Neurodegener Dis; 2012; 10(1-4):64-72. PubMed ID: 22156588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]